Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cara: Q3 Earnings Snapshot AP - Thu Nov 14, 6:31PM CST

Cara: Q3 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Cara: Q2 Earnings Snapshot AP - Thu Aug 15, 12:55PM CDT

Cara: Q2 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Cara: Q1 Earnings Snapshot AP - Mon May 13, 3:07PM CDT

Cara: Q1 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Cara: Q4 Earnings Snapshot AP - Mon Mar 4, 3:21PM CST

Cara: Q4 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Charts, tickers, traders - iStock-884650780
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why Barchart Impact - Wed Nov 29, 2023

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 1.0600 (+6.00%)
CARA : 0.4226 (+3.35%)
CRBP : 13.00 (-2.48%)
HRMY : 34.28 (+1.15%)
JAZZ : 122.97 (+0.10%)
Cara: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Cara: Q3 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Cara: Q2 Earnings Snapshot AP - Mon Aug 7, 2023

Cara: Q2 Earnings Snapshot

CARA : 0.4226 (+3.35%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus Newswire.ca - Thu May 18, 2023

/CNW/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute for...

CARA : 0.4226 (+3.35%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus PR Newswire - Thu May 18, 2023

/PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute...

CARA : 0.4226 (+3.35%)
Cara: Q1 Earnings Snapshot AP - Mon May 15, 2023

Cara: Q1 Earnings Snapshot

CARA : 0.4226 (+3.35%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 1 hour ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot